A pioneering lab dedicated to biology and infection research has opened in Hamburg, strengthening cooperation between the German city’s universities and research institutions as well as cementing its reputation as a medical hub.
The Leibniz Science Campus named InterACt or “integrated analysis of pathogen-induced compartments” opened May 1 and is the product of a partnership between the Heinrich Pette Institute, Leibniz Institute for Experimental Virology (HPI) and the University of Hamburg.
More Than 6 Million Euros in Funding
InterACt is designed to further the city’s reputation in the field of structural systems biology and infection research. InterACt is located near the CCH – Congress Center Hamburg — which is undergoing an expansion and is set to reopen in 2020 — and over the next four years, will receive a total of 6.6 million euros in funding.
Professor Dr. Dieter Lenzen, president of the University of Hamburg, said: “The creation of a new Leibniz Science Campus devoted to infection research is yet another example of the excellent cooperation between the university and non-university research institutions in the city.”
Hamburg’s Health-Care Cluster
Hamburg — Germany’s second-largest city — has an international reputation as a health-care location with one out of seven employees working in the health-care sector and one of the highest densities of medical doctors in Germany. Hamburg’s health-care cluster combines the expertise of the city’s the health-care sector with medical associations and other interest groups.
Karine Serra, marketing manager conventions — medical, health care and life science at the Hamburg Convention Bureau, explains: “Our cluster initiative aims to strengthen Hamburg’s reputation as a leading health-care location and also build relationships between experts in the sector and meeting planners. The new Leibniz Science Campus is a reflection of the city’s dedication to supporting pioneering medical research.”
This article was contributed by Boardroom. It was edited for use in Communique.